Media
CellCentric Discovery May Slow Down Cancer’s March
CellCentric has discovered and patented a small molecule inhibitor that makes it more difficult for cancer cells to survive and thrive in the body. The company believes it could slow the advance of prostate, lung and bladder cancers. Globalive Chairman Anthony Lacavera sits down with the company’s Executive Chairman Will West. (Source: Bloomberg)
CellCentric Discovery May Slow Down Cancer’s March Read More »
